Why are Medicare and Medicaid shown separately instead of combined?

They come from two different CMS data sources with no shared claim identifier, so they can't be reconciled into one number without double-counting or guessing. Every table and chart on this page keeps them fully separate.

Why is there no private/commercial revenue figure?

Private and commercial payer data comes from Transparency in Coverage files, which only publish negotiated rates — not claims or utilization volume. Without a volume figure, no revenue number can be computed for any provider from that data.

What does "Rank" mean in the Competitive Analysis & Benchmarks tables?

For a given CPT/HCPCS code, it's this provider's position by claims volume among all providers billing that same code at that geography level (State, National, or Nebraska for Medicaid) — rank 1 means the highest claims volume for that code.

Why is the Medicaid comparison limited to Nebraska only?

Medicaid is administered per-state with no single national fee schedule, so a state or national comparison the way Medicare has one isn't available. Nebraska (this provider's own state) is the only grouping that's conceptually meaningful.

Why are the numbers rounded to the nearest 10?

To avoid implying more precision than the underlying data supports at a single-provider level. Ratios are kept precise since they're a relative comparison, not a volume or dollar figure.

How current is this data?

The Medicare and Medicaid tables are both single current snapshots, not refreshed on a recurring schedule yet.

Daniel Chruscicki (NPI 1861666463)

Field	Value
Entity Type	Individual
Organization	Daniel Chruscicki
Address	1710 S 70th St
City	Lincoln
State	NE
ZIP	68506
Taxonomy	Ophthalmology Physician
NPI Enumerated	April 15, 2008

Payer Source	Total Paid
Medicare	$3M
Medicaid	$0

Key Findings

This ophthalmology physician has generated $3M in lifetime Medicare revenue and no Medicaid billing on file, making their active payer mix effectively single-payer (Medicare-only) for the available claims data. The absence of Medicaid claims indicates the provider either does not participate in Medicaid or has not billed Medicaid during the recorded period; analyses comparing Medicaid volumes are therefore not applicable.

Revenue is highly concentrated in a small set of injectable biologic codes: the precomputed top three Medicare codes account for 81.2% of this provider's total Medicare revenue. Specifically, J0178, J2777, and 67028 together drive the majority of billed dollars, signaling that intravitreal pharmacologic therapy is the principal revenue stream.

J0178 (injection, aflibercept) is the single largest source of Medicare revenue at $1.3M (41.4% of total Medicare revenue) and ranks #629 of 3204 providers nationally (80th percentile). This places the provider as a solid national participant in aflibercept administration — neither dominant nor rare — and confirms that high-volume anti-VEGF injections are central to clinical activity.

J2777 (injection, faricimab-svoa) contributes $1M (33.6% of Medicare revenue) with a national rank of #216 of 2039 providers (89th percentile). This relatively high percentile for J2777, combined with the J0178 volume, reinforces a treatment profile focused on frequent intravitreal biologic therapy and suggests the practice is an above-typical regional user of newer biologic agents.

67028 (intravitreal injection as an isolated procedure) accounts for $187.5K (6.2% of Medicare revenue) and ranks #226 of 4255 providers nationally (95th percentile), described as notably above typical national volume. The strong rank for 67028 indicates the provider performs injections at a rate well above peers, consistent with the concentrated revenue from injectable anti-VEGF therapies and a procedure-forward outpatient ophthalmology workflow.

Several diagnostic and imaging codes appear at unusually high national percentiles, highlighting a high-throughput retinal imaging and exam practice. 92134 (retinal imaging) and 92014 (comprehensive established eye exam) are both reported as extreme outliers at the 99th percentile, and 92235 (fluorescein angiography) is notably above typical volume at the 98th percentile, indicating substantial ancillary diagnostic activity that supports frequent therapeutic injections and retinal disease management.

Other code-level observations show a mixed competitive standing across services: J3590 (unclassified biologics) and 92250 (fundus photography) are notably above typical volumes (96th and 98th percentiles respectively), while codes such as J2778 (ranibizumab) and several standard E/M codes (99214, 99213) are at typical or lower national percentiles. This pattern suggests the provider emphasizes procedural and imaging services tied to retinal disease rather than high-volume office-based E/M visits.

Tenure data shows the NPI was enumerated on 2008-04-15 (~18 years ago), indicating long-standing Medicare participation. That tenure, combined with concentrated high-volume injection and imaging activity, suggests an established retinal-focused ophthalmology practice with sustained procedural throughput.

Medicare: Complete Services Breakdown

The CPT/HCPCS codes generating the most Medicare revenue for this provider.

21 rows

CPT/HCPCS Code	Description	Claims	Avg Paid	Revenue
J0178	Injection, aflibercept, 1 mg	1,810	$690	$1.3M
J2777	Injection, faricimab‑svoa, 0.1 mg	35,040	$30	$1M
67028	The provider injects a medication into the vitreous chamber of the eye as an isolated procedure or a separate procedure unrelated to any other procedure being performed on the eye.	2,370	$80	$187.5K
92014	An ophthalmologist sees an established patient for a comprehensive level eye examination. Generally, a patient is considered to be "established" if the same physician, or any physician in the group…	1,970	$90	$167.4K
92134	The provider performs computerized diagnostic imaging of the retina in the posterior segment (back part) of the eye, interprets the data, and provides a report. The service may be on one or both eyes.	3,440	$30	$92.9K
92235	The provider uses a special dye, fluorescein that causes the blood vessels in the one or both eyes to stand out in photographic images taken with the use of multiframe timing, or serial images, taken…	680	$100	$65.8K
J2778	Injection, ranibizumab, 0.1 mg	350	$180	$63K
J3590	Unclassified biologics	810	$70	$56K
99214	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the…	350	$70	$24.6K
92004	The provider performs a comprehensive level ophthalmological evaluation of a new patient and initiates a diagnostic and treatment program for one or more visits.	240	$90	$22K

Showing 1–10 of 21

Medicare: Competitive Analysis & Benchmarks

How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 21 CPT/HCPCS codes.

View: State1 / 2

Claims Volume vs. Nebraska Distribution

Daniel Chruscicki — 7 of 21 codes billed far more than typical (above p95)

p5–p95 (all providers)p25–p75MedianThis providerOutlier

Rank Distribution — Nebraska

Full comparison — all codes billed, vs. state median

21 rows

CPT/HCPCS Code	Rank	Provider Count	Median Claims	Avg Paid	Average Revenue
J2777	5	10	25,950	$30	$1.5M
J0178	4	20	880	$690	$722.7K
J2778	11	10	670	$180	$137.8K
67028	5	20	1,070	$80	$106.4K
J3590	2	10	430	$70	$29.7K
67042	8	10	30	$1,100	$29.6K
67108	7	10	20	$1,040	$20.8K
92014	1	270	170	$70	$20K
99214	551	3,210	110	$70	$14.9K
92235	1	10	30	$100	$11.2K

Showing 1–10 of 21

Related Providers

Other providers that share a Tax Identification Number (TIN) with Daniel Chruscicki, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Matthew Wood	NE	Ophthalmology Physician	$3.9M	$0
Eye Surgical Associates, LLC	NE	Ophthalmology Physician	$0	$1.7M
Gregory Sutton	NE	Ophthalmology Physician	$565.7K	$0
Jordan Rixen	NE	Ophthalmology Physician	$490.2K	$0
Vincent Sutton	NE	Ophthalmology Physician	$447.8K	$0
Samuel Thomsen	NE	Ophthalmology Physician	$428.3K	$0
Thomas Clark	NE	Ophthalmology Physician	$282.1K	$0
Thomas Graul	NE	Ophthalmology Physician	$218.6K	$0
Donald Sauberan	NE	Ophthalmology Physician	$10.9K	$0

Nearby Providers

Other providers in the same ZIP code as Daniel Chruscicki, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Bryan Medical Center	NE	General Acute Care Hospital	$0	$56.9M
Integrated Behavioral Health Services	NE	Community/Behavioral Health Agency	$0	$16.3M
Nebraska Emergency Medicine PC	NE	Emergency Medicine Physician	$0	$14.9M
Firstcare Home Health Of Eastern Nebraska, Inc	NE	Home Health Agency	$0	$6.6M
Eric Avery	NE	Hematology & Oncology Physician	$3.1M	$0
Kailash Mosalpuria	NE	Hematology & Oncology Physician	$2.9M	$0
Integrated Cardiology Group LLC	NE	Cardiovascular Disease Physician	$0	$2.7M
Madhu Midathada	NE	Hematology & Oncology Physician	$2.3M	$0
Pathology Medical Services PC	NE	Anatomic Pathology & Clinical Pathology Physician	$0	$2.1M
Rockledge Smiles LLC	NE	General Practice Dentistry	$0	$2.1M

Daniel Chruscicki — Billing Profile & Reimbursement Data

Sign up for Daniel Chruscicki — Billing Profile & Reimbursement Data policy alerts

Daniel Chruscicki — Billing Profile & Reimbursement Data

Sign up for Daniel Chruscicki — Billing Profile & Reimbursement Data policy alerts

Key Findings

Medicare: Total Revenue Breakdown by CPT/HCPCS Code

Medicare: Complete Services Breakdown

Medicare: Competitive Analysis & Benchmarks

Related Providers

Nearby Providers

Frequently Asked Questions

References